Article
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.
Scientific reports - 25 Apr 2023
Gomes Diana, Sobolewski Cyril, Conzelmann Stéphanie, Schaer Tifany, Lefai Etienne, Alfaiate Dulce, Tseligka Eirini D, Goossens Nicolas, Tapparel Caroline, Negro Francesco, Foti Michelangelo, Clément Sophie
Abstract excerpt
Chronic hepatitis C (CHC) is associated with the development of metabolic disorders, including both hepatic and extra-hepatic insulin resistance (IR). Here, we aimed at identifying liver-derived factor(s) potentially inducing peripheral IR and uncovering the mechanisms whereby HCV can regulate the action of these factors. We found ANGPTL4 (Angiopoietin Like 4) mRNA expression levels to positively correlate with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
